New

From idea to ETF portfolio in minutes. Build yours now →

Advertisement
Advertisement

HRTSvsFHLCETF Comparison

ETF 1
HRTS

Tema GLP-1, Obesity & Cardiometabolic ETF

This fund is part of
Tomorrow's Treatments
-1.28%
VS
ETF 2
FHLC

Fidelity MSCI Health Care Index ETF

This fund is part of
US Health Care
-0.77%

Tema GLP-1, Obesity & Cardiometabolic ETF (HRTS) belongs to the Tomorrow's Treatments segment. Fidelity MSCI Health Care Index ETF (FHLC) is part of the US Health Care segment. Both ETFs have the same top 3 sector exposures: and Health Care. HRTS is more expensive with a Total Expense Ratio (TER) of 0.99%, versus 0.08% for FHLC. HRTS is down -7.09% year-to-date (YTD) with -$2M in YTD flows. FHLC performs better with -6.2% YTD performance, and +$171M in YTD flows. Run a side-by-side ETF comparison of HRTS and FHLC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

HRTS vs FHLC performance and flow charts

Performance

0.01.02.03.04.05.06.0%Mar 30Apr 7Apr 14Apr 21Apr 28

Cumulative Flows

0 M10 M20 M30 M40 M50 MMar 30Apr 7Apr 14Apr 21Apr 28

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 04/29/2026
1M3MYTD1Y3Y5Y
Perf.
HRTS
FHLC
+0.22%+0.93%
-7.83%-5.89%
-7.09%-6.20%
+15.13%+8.27%
n/a+14.54%
n/a+20.29%
Flows
HRTS
FHLC
-$1M+$50M
-$4M+$183M
-$2M+$171M
-$12M+$117M
--$537M
--$143M
Volatility and drawdown
3M1Y3Y5Y
Volatility
HRTS
FHLC
+16.39%+14.93%
+16.33%+15.52%
n/a+13.80%
n/a+14.91%
Max drawdown
HRTS
FHLC
-9.68%-9.85%
-10.68%-10.35%
n/a-16.88%
n/a-17.78%
Max drawdown duration
HRTS
FHLC
59d58d
112d111d
n/a435d
n/a762d
Trading data

Create an account to view trading data

Join for free
HRTS
FHLC
Last sale
4/29/2026 at 6:04 PM
$32.74
$70.38
Previous close
04/29/2026
$33.15
$68.94
Consolidated volume
04/29/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of March 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

HRTS
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
HRTS
FHLC
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 4/29/2026 at 6:04 PM
Live
Closed
HRTS
FHLC
Last price
$32.74
$70.38
1D performance
-1.22%
+2.09%
AuM$48.91 M$2.82 B
E/R0.99%0.08%
Characteristics
HRTS
FHLC
Management strategyActivePassive
ProviderTemaFidelity
Benchmark-MSCI USA IMI Health Care 25/50 Index
N° of holdings38284
Asset class--
Trailing 12m distribution yield
Join
Join
Inception dateNovember 21, 2023October 21, 2013
ESGNoNo
Advertisement
Exposure

Countries

HRTS
USA
82.47%
Other
17.53%
FHLC
USA
96.47%
Other
3.53%

Sectors

HRTS
Health Care
87.86%
Other
12.14%
FHLC
Health Care
97.4%
Other
2.6%

Diversification

HRTS

Total weight of top 15 holdings out of 15

61.52%
FHLC

Total weight of top 15 holdings out of 15

60.44%

Top 15 holdings

Data as of March 31, 2026
HRTS
LILLY
9.70%
JOHNSON&JOHNSON
4.97%
US7711951043
4.94%
ASTRAZENECA
4.91%
MERCK & CO INC
4.46%
THERMO FISHER SCIENTIFIC
4.06%
UNITEDHEALTH GRP
3.79%
GILEAD SCIENCES
3.66%
NOVARTIS
3.52%
VERTEX PHARMACEUTICALS
3.30%
ABBOTT LABS
3.26%
ABBVIE
3.00%
BRIDGEBIO PHARMA
2.85%
DANAHER
2.81%
BRISTOL-MYERS SQUIBB
2.29%
FHLC
LILLY
11.69%
JOHNSON&JOHNSON
9.35%
ABBVIE
6.05%
MERCK & CO INC
4.79%
UNITEDHEALTH GRP
3.94%
AMGEN-T
3.08%
THERMO FISHER SCIENTIFIC
2.98%
ABBOTT LABS
2.95%
GILEAD SCIENCES
2.75%
INTUITIVE SURGICAL
2.69%
PFIZER
2.54%
BRISTOL-MYERS SQUIBB
1.96%
DANAHER
1.93%
VERTEX PHARMACEUTICALS
1.87%
STRYKER
1.86%
Frequently asked questions about HRTS and FHLC

How have the HRTS and FHLC ETFs performed in 2026?

As of April 29, 2026, HRTS is down -7.09% year-to-date (YTD), while FHLC has lost -6.2%. That puts FHLC better performer ahead so far this year.

Which ETF is attracting more investor money: HRTS or FHLC?

Year-to-date, the HRTS ETF saw -$2M in flows, compared to +$171M for FHLC.

Which ETF is more volatile: HRTS or FHLC?

Over the past year, HRTS had a volatility of 16.33%, while FHLC experienced 15.52%.

Which ETF is bigger: HRTS or FHLC?

As of April 29, 2026, HRTS holds $48.91 M in assets under management (AUM), while FHLC manages $2.82 B.

What sectors do the HRTS and FHLC ETFs invest in?

HRTS leans toward sectors like Health Care. Meanwhile, FHLC focuses on Health Care.

What are the top holdings of the HRTS ETF and FHLC ETF?

HRTS top holdings include LILLY, JOHNSON&JOHNSON and US7711951043. FHLC holds in its top three: LILLY, JOHNSON&JOHNSON and ABBVIE.

Which ETF is more diversified: HRTS or FHLC?

HRTS holds 44 securities with 61.52% of its assets in the top 15. FHLC has 337 securities and a top 15 weight of 60.44%.

Advertisement
Advertisement
Advertisement
Webcast on Demand

Calamos Investments Powers the Next Phase of the Autocallable Revolution

Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.

Accepted for 1 CE Credit

Calamos Webcast